NEW DELHI: Tomorrow Capital, a $100 million VC fund, is investing $2.7 million in VitusCare as part of its Series A funding round.
VitusCare, a kidney care start-up founded in 2017, has emerged as a player of quality dialysis care, particularly in regions where access to such services is limited, a company statement said.
The fresh capital injection will empower VitusCare to aggressively expand its operations, with a targeted focus on deeper penetration into the hinterland.
In addition, the funding round saw participation from existing investor 1Crowd, alongside support from 3i Partners and a consortium of angel investors, totalling approximately $5 million in funding across all the funding rounds.
Tomorrow Capital, part of Lodha Ventures, has investments in healthcare, fitness and education.
India has over 5 million patients suffering from ESRD (end-stage renal disease), however, only about 5% of these receive regular dialysis with reasons ranging from affordability, lack of awareness and access. Even today, most dialysis services are skewed towards the bigger cities, further compounding this problem.


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *